myLaurel® | $12,000,000 | (Jun 4, 2025)
Matterworks | Undisclosed Amount | (Jun 4, 2025)
Ciroos | $21,000,000 | (Jun 4, 2025)
Certified by Founder
Lodge
Scorpion Therapeutics
start up
- 17/07/2024
- Series C
- $150,000,000
Scorpion Therapeutics was founded to expand the reach of precision medicine to more people with cancer. The company is integrating cutting-edge technologies across target discovery, medicinal chemistry, and translational medicine to deliver Precision Oncology 2.0, a pipeline of targeted small-molecule drugs that overcome the limitations of existing treatments. Scorpion’s experienced leadership team is executing a fit-to-purpose model to efficiently unlock the next generation of precision oncology. For more information, visit scorpiontx.com.
- Industry Biotechnology Research
- Website https://www.scorpiontx.com/
- LinkedIn https://www.linkedin.com/company/scorpiontherapeutics/
FISPAN | $30,000,000 | (Jun 4, 2025)
Veris AI | $8,500,000 | (Jun 4, 2025)
Limited | $7,000,000 | (Jun 3, 2025)
Dexari | $2,300,000 | (Jun 3, 2025)
Heron Power | $38,000,000 | (Jun 3, 2025)
Trustifi | $25,000,000 | (Jun 3, 2025)
Infleqtion | $100,000,000 | (Jun 3, 2025)
Literal Labs | $6,223,938 | (Jun 3, 2025)
Moments Lab | $24,000,000 | (Jun 3, 2025)